Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hematologic disorders in rheumatic disease.

R D Sturrock1

  • 1Centre for Rheumatic Diseases, Royal Infirmary, Glasgow, Scotland, UK.

Current Opinion in Rheumatology
|February 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The clinical significance of indomethacin-probenecid interaction.

British journal of clinical pharmacology·2012
Same author

Elucidating the chromosome 9 association with AS; CARD9 is a candidate gene.

Genes and immunity·2010
Same author

Comparison of cardiovascular risk in ankylosing spondylitis and rheumatoid arthritis.

Clinical and experimental rheumatology·2009
Same author

Angiotensin receptor blockers reduce erythrocyte sedimentation rate levels in patients with rheumatoid arthritis.

Annals of the rheumatic diseases·2008
Same author

Ankylosing spondylitis.

Scottish medical journal·2007
Same author

Angiotensin II type 1 receptor as a novel therapeutic target in rheumatoid arthritis: in vivo analyses in rodent models of arthritis and ex vivo analyses in human inflammatory synovitis.

Arthritis and rheumatism·2007
Same journal

New approaches to the management of cutaneous lupus.

Current opinion in rheumatology·2026
Same journal

"Updates in chronic nonbacterial osteomyelitis: emerging insights across the age spectrum".

Current opinion in rheumatology·2026
Same journal

Difficult-to-treat, complex-to-manage, treatment-refractory spondyloarthritis: semantics or substance?

Current opinion in rheumatology·2026
Same journal

Update on IgA nephropathy: implications for treatment in IgA vasculitis: a guide for rheumatologists.

Current opinion in rheumatology·2026
Same journal

Polyarticular juvenile idiopathic arthritis: insights from genetic studies on disease risk and pathogenesis.

Current opinion in rheumatology·2026
Same journal

Immune dysregulation in children with Down syndrome: clinical implications and emerging therapies.

Current opinion in rheumatology·2026
See all related articles

This review covers hematologic disorders in rheumatic diseases, focusing on anemia of chronic disease and generalized reticuloendothelial hyperplasia. The latter, associated with heavy-chain disease, can mimic sepsis in rheumatoid arthritis patients.

Area of Science:

  • Rheumatology
  • Hematology
  • Internal Medicine

Background:

  • Hematologic disorders are common in rheumatic diseases.
  • Anemia of chronic disease is a well-documented comorbidity.
  • Generalized reticuloendothelial hyperplasia is a less recognized complication.

Purpose of the Study:

  • To review the 1990 literature on hematologic disorders in rheumatic diseases.
  • To highlight key findings regarding anemia of chronic disease.
  • To identify and describe generalized reticuloendothelial hyperplasia as a complication.

Main Methods:

  • Literature review of publications from 1990.
  • Identification of major themes in hematologic manifestations of rheumatic diseases.
  • Synthesis of information on anemia of chronic disease and reticuloendothelial hyperplasia.

Related Experiment Videos

Main Results:

  • Anemia of chronic disease is linked to various medical conditions.
  • Generalized reticuloendothelial hyperplasia is associated with heavy-chain disease.
  • This hyperplasia can be misdiagnosed as sepsis in rheumatoid arthritis.

Conclusions:

  • Hematologic issues require careful consideration in rheumatic disease management.
  • Recognition of generalized reticuloendothelial hyperplasia is crucial for accurate diagnosis and treatment in rheumatoid arthritis patients.